Silence Therapeutics (SLN) News Today → He Is Giving Away Bitcoin (From Crypto Swap Profits) (Ad) Free SLN Stock Alerts $20.41 +0.11 (+0.54%) (As of 12:19 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 31, 2024 | americanbankingnews.comHC Wainwright Reiterates "Buy" Rating for Silence Therapeutics (NASDAQ:SLN)May 30, 2024 | businesswire.comSilence Therapeutics to Present at Jefferies Global Healthcare ConferenceMay 24, 2024 | marketbeat.comSilence Therapeutics (NASDAQ:SLN) Given "Buy" Rating at HC WainwrightHC Wainwright restated a "buy" rating and issued a $75.00 price objective on shares of Silence Therapeutics in a research note on Friday.May 23, 2024 | marketbeat.comSilence Therapeutics (NASDAQ:SLN) Trading Down 7.4%Silence Therapeutics (NASDAQ:SLN) Stock Price Down 7.4%May 21, 2024 | marketbeat.comSilence Therapeutics (NASDAQ:SLN) Trading Up 4.4%Silence Therapeutics (NASDAQ:SLN) Trading Up 4.4%May 17, 2024 | markets.businessinsider.comWhat 7 Analyst Ratings Have To Say About Silence TherapeuticsMay 16, 2024 | investorplace.comSLN Stock Earnings: Silence Therapeutics Reported Results for Q1 2024May 16, 2024 | businesswire.comSilence Therapeutics Reports First Quarter 2024 Results and Highlights Pipeline ProgressMay 11, 2024 | marketbeat.comSilence Therapeutics plc (NASDAQ:SLN) Sees Large Growth in Short InterestSilence Therapeutics plc (NASDAQ:SLN - Get Free Report) was the target of a significant increase in short interest in the month of April. As of April 30th, there was short interest totalling 297,200 shares, an increase of 104.0% from the April 15th total of 145,700 shares. Based on an average daily volume of 228,000 shares, the short-interest ratio is presently 1.3 days.May 9, 2024 | marketbeat.comVivo Capital LLC Invests $8.86 Million in Silence Therapeutics plc (NASDAQ:SLN)Vivo Capital LLC bought a new position in shares of Silence Therapeutics plc (NASDAQ:SLN - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 510,204 shares of the company's stock, valued atApril 30, 2024 | businesswire.comSilence Therapeutics to Participate in Fireside Chat at H.C. Wainwright 2nd Annual BioConnect Investor ConferenceApril 29, 2024 | businesswire.comSilence Therapeutics Announces Retirement of Alistair Gray from Board of DirectorsApril 27, 2024 | marketbeat.comVivo Capital LLC Buys 595,250 Shares of Silence Therapeutics plc (NASDAQ:SLN)Vivo Capital LLC lifted its position in Silence Therapeutics plc (NASDAQ:SLN - Free Report) by 116.7% during the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 1,105,454 shares of the company's stock after purchasing an additional 595,250 shares during the period.April 22, 2024 | marketbeat.comSilence Therapeutics (NASDAQ:SLN) Receives Overweight Rating from Morgan StanleyMorgan Stanley reissued an "overweight" rating and issued a $45.00 price objective on shares of Silence Therapeutics in a research report on Monday.April 16, 2024 | marketbeat.comSilence Therapeutics (NASDAQ:SLN) Trading Up 3.2%Silence Therapeutics (NASDAQ:SLN) Trading Up 3.2%April 13, 2024 | yahoo.comA youth's call to action on this Day of NO SilenceApril 12, 2024 | marketbeat.comSilence Therapeutics plc (NASDAQ:SLN) Short Interest UpdateSilence Therapeutics plc (NASDAQ:SLN - Get Free Report) was the target of a large growth in short interest in March. As of March 31st, there was short interest totalling 162,000 shares, a growth of 74.8% from the March 15th total of 92,700 shares. Based on an average daily volume of 241,700 shares, the days-to-cover ratio is currently 0.7 days.April 11, 2024 | marketbeat.comSilence Therapeutics (NASDAQ:SLN) Sees Strong Trading VolumeSilence Therapeutics (NASDAQ:SLN) Sees Unusually-High Trading VolumeApril 11, 2024 | investorplace.com3 Biotech Stocks to Turn $5,000 Into $1 Million: April 2024April 9, 2024 | marketbeat.comSilence Therapeutics (NASDAQ:SLN) Stock Price Down 4.5%Silence Therapeutics (NASDAQ:SLN) Shares Down 4.5%April 8, 2024 | businesswire.comSilence Therapeutics Announces JAMA Publication of Additional Phase 1 Data for Zerlasiran in Subjects with Elevated Lipoprotein(a)April 1, 2024 | yahoo.comThe Lady of Silence: The Mataviejitas Murders Streaming: Watch & Stream Online via NetflixMarch 18, 2024 | investorplace.com7 Biotech Stocks Ready to Ride the Sector's ResurgenceMarch 18, 2024 | marketbeat.comSilence Therapeutics (NASDAQ:SLN) Price Target Raised to $42.00 at Chardan CapitalChardan Capital upped their target price on Silence Therapeutics from $26.00 to $42.00 and gave the company a "buy" rating in a research note on Thursday.March 18, 2024 | marketbeat.comSilence Therapeutics (NASDAQ:SLN) Shares Gap Up to $22.84Silence Therapeutics (NASDAQ:SLN) Shares Gap Up to $22.84March 16, 2024 | finance.yahoo.comAnalysts Are Upgrading Silence Therapeutics plc (NASDAQ:SLN) After Its Latest ResultsMarch 15, 2024 | seekingalpha.comSilence Therapeutics plc (SLN) Q4 2023 Earnings Call TranscriptMarch 15, 2024 | marketbeat.comSilence Therapeutics (NASDAQ:SLN) Stock Price Down 5.5%Silence Therapeutics (NASDAQ:SLN) Trading Down 5.5%March 15, 2024 | finance.yahoo.comSilence Therapeutics plc (NASDAQ:SLN) Q4 2023 Earnings Call TranscriptMarch 14, 2024 | marketbeat.comSilence Therapeutics (NASDAQ:SLN) Hits New 12-Month High at $27.72Silence Therapeutics (NASDAQ:SLN) Hits New 52-Week High at $27.72March 13, 2024 | yahoo.comLocal authors 'Break the Silence' with book anthology to share the stories of survivorsMarch 13, 2024 | sg.finance.yahoo.comSingTel looking to sell significant Optus stake to Brookfield - sourceMarch 13, 2024 | marketbeat.comSilence Therapeutics (NASDAQ:SLN) Shares Gap Down to $25.90Silence Therapeutics (NASDAQ:SLN) Shares Gap Down to $25.90March 13, 2024 | seekingalpha.comSilence Therapeutics plc 2023 Q4 - Results - Earnings Call PresentationMarch 13, 2024 | businesswire.comSilence Therapeutics Reports Full Year 2023 Financial Results and Recent Business HighlightsMarch 13, 2024 | businesswire.comSilence Therapeutics Announces Positive Topline 36-Week Data from Ongoing Phase 2 Study of Zerlasiran in Patients with High Lipoprotein(a)March 12, 2024 | markets.businessinsider.comSilence Therapeutics earnings: here's what Wall Street expectsMarch 5, 2024 | marketbeat.comSilence Therapeutics (NASDAQ:SLN) Sets New 12-Month High at $26.74Silence Therapeutics (NASDAQ:SLN) Sets New 52-Week High at $26.74February 28, 2024 | finance.yahoo.comSilence Therapeutics to Report Fourth Quarter and Full Year 2023 Results on March 13, 2024February 28, 2024 | businesswire.comSilence Therapeutics to Report Fourth Quarter and Full Year 2023 Results on March 13, 2024February 24, 2024 | seekingalpha.comSilence Therapeutics: Multiple 2024 Catalysts Make This mRNA Biotech Worth A LookFebruary 23, 2024 | businesswire.comSilence Therapeutics Achieves $10 Million Milestone Payment from AstraZeneca Collaboration Following the Initiation of Phase 1 TrialFebruary 22, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Silence Therapeutics (SLN) and Aurinia Pharmaceuticals (AUPH)February 21, 2024 | marketbeat.comSilence Therapeutics (NASDAQ:SLN) Sets New 52-Week High at $25.00Silence Therapeutics (NASDAQ:SLN) Hits New 12-Month High at $25.00February 16, 2024 | finance.yahoo.comRecursion Pharmaceuticals (RXRX) Surges 13.8%: Is This an Indication of Further Gains?February 12, 2024 | investing.comSilence Therapeutics PLC (SLN)February 5, 2024 | marketbeat.comSilence Therapeutics (NASDAQ:SLN) Shares Up 1.9%Silence Therapeutics (NASDAQ:SLN) Trading Up 1.9%February 5, 2024 | finance.yahoo.comSilence Therapeutics Announces Oversubscribed $120 Million Private PlacementJanuary 31, 2024 | marketbeat.comSilence Therapeutics (NASDAQ:SLN) Reaches New 1-Year High at $24.33Silence Therapeutics (NASDAQ:SLN) Hits New 52-Week High at $24.33January 31, 2024 | marketbeat.comSilence Therapeutics (NASDAQ:SLN) Now Covered by BMO Capital MarketsBMO Capital Markets assumed coverage on shares of Silence Therapeutics in a research report on Wednesday. They set an "outperform" rating and a $67.00 price target for the company. Get Silence Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SLN and its competitors with MarketBeat's FREE daily newsletter. Email Address Breaking - The US Gov. Seized CITGO (Ad)Do you want an investment that can double or triple your money in the next three months? The US Court is currently auctioning off CITGO (the winning bid will be announced on July 22nd). Get all the details here. SLN Media Mentions By Week SLN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SLN News Sentiment▼0.300.73▲Average Medical News Sentiment SLN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SLN Articles This Week▼21▲SLN Articles Average Week Get Silence Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SLN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: GERN News RYTM News BHC News DCPH News VERA News MRVI News AMPH News AMRX News RCKT News ARVN News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SLN) was last updated on 6/7/2024 by MarketBeat.com Staff From Our PartnersCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredProtect Your Bank Account Before It’s Too LateFor months I’ve been warning about the federal government’s terrifying new program to control every American’s...Weiss Ratings | SponsoredAlert: Your Bank is Dying – Act Now or Lose Everything!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put...Priority Gold | SponsoredPrepare for a Recession Unlike Any OtherDave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dav...American Hartford Gold Group | SponsoredBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredHe Is Giving Away BitcoinAnd my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a v...Crypto Swap Profits | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | Sponsored